CORDIS
EU research results

CORDIS

English EN

Health impacts of long-term exposure to disinfection by-products in drinking water

Objective

The overall aim is to investigate potential human health risks associated with long-term exposure to low levels of disinfectants (such as chlorine) and disinfectant by-products (DBPs) occurring in water for human sumption and use in the food industry. The study will comprise risk/benefit analyses including quantitative assessments of risk associated with microbial tamination of drinking water versus chemical risk and will compare alternative treatment options. The outcome will be improved risk assessment and management. The study will make use of existing studies/databases and newly collected information. Specific objectives are: I) To determine the DBP composition and levels in drinking water in various regions in Europe II) To identify the determinants of DBPs and develop predictive models III) To assess the risk of small for gestational age, premature birth, semen quality, stillbirth and genital anomalies in relation to disinfection practices and levels of DBPs, including any gene-environment interactions where possible IV) To assessment the risk of cancer, particularly bladder cancer and colon cancer, in relation to DBP levels, including any gene-environment interactions V) duct risk/benefit analyses including quantitative assessments of risk associated with microbial tamination of drinking water versus chemical risk, compare alternative treatment options, and produce burden of disease estimates (e.g. DALYs) VI) To review the water and health policies in Europe, USA and worldwide in relation to water disinfection. VII) To assess the policy implications of current disinfection practices Water samples will be collected and analysed for a range of DBPs to give a wider picture on their levels and determinants. Epidemiological studies will be ducted or existing studies used to examine the relationship between DBPs and various outcomes to provide risk estimates for the risk/benefit analysis.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

Address

Exhibition Road
London

United Kingdom

Administrative Contact

Mark NIEUWENHUIJSEN (Dr)

Participants (15)

Sort alphabetically

Expand all

NATIONAL INSTITUTE FOR HEALTH AND WELFARE

Finland

VYTAUTAS MAGNUS UNIVERSITY

Lithuania

UNIVERSITY OF CRETE

Greece

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

FUNDACIÓ IMIM

Spain

CENTRE DE REGULACIÓ GENÒMICA

Spain

UNIVERSITA' DI MODENA E REGGIO EMILIA

Italy

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

Italy

SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL (SMITTSKYDDSINSTITUTET)

Sweden

HYLOBATES CONSULTING SRL

Italy

IC CONSULTANTS LTD

United Kingdom

SCARAB DEVELOPMENT AB

Sweden

FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGICA AMBIENTAL

Spain

CATALAN INSTITUTE OF ONCOLOGY

Spain

UNIVERSITY OF THE AEGEAN

Greece

Project information

Grant agreement ID: 36224

  • Start date

    1 November 2006

  • End date

    31 August 2010

Funded under:

FP6-FOOD

  • Overall budget:

    € 3 715 600

  • EU contribution

    € 3 469 736

Coordinated by:

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom